NCT07047131

Brief Summary

This study compares two bone graft materials used when placing a dental implant right after tooth removal. One graft fully dissolves (GTO®), the other only partly (Apatos®). The goal is to see which one better preserves bone and improves appearance around the implant.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for phase_3

Timeline
56mo left

Started Dec 2018

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Dec 2018Dec 2030

Study Start

First participant enrolled

December 18, 2018

Completed
6.5 years until next milestone

First Submitted

Initial submission to the registry

June 24, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 2, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2030

Expected
Last Updated

July 4, 2025

Status Verified

July 1, 2025

Enrollment Period

7 years

First QC Date

June 24, 2025

Last Update Submit

July 1, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in peri-implant bone volumes

    Volumetric changes in peri-implant tissues will be measured using limited-view CBCT scans taken at implant placement (baseline), 1 year, and 5 years after loading. The main endpoint is the difference in bone volume between baseline and 1 year.

    From enrollment to 5 years after implant loading

Secondary Outcomes (4)

  • Number of participants with crown or implant failure

    From enrollment to 5 years after implant loading

  • Number of biological and biomechanical complications

    From enrollment to 5 years after implant loading

  • Peri-implant marginal bone level changes

    From enrollment to 5 years after implant loading

  • Aesthetic evaluation using the Pink Esthetic Score (0-14; higher scores = better outcome)

    From enrollment to 5 years after implant loading

Study Arms (2)

Resorbable Bone Substitute (GTO®)

EXPERIMENTAL

Patients receive a fully resorbable bone substitute (GTO®) to fill the gap between the implant and the buccal bone wall during immediate post-extraction implant placement.

Biological: GTO® (fully resorbable bone substitute)

Partially Resorbable Bone Substitute (Apatos®)

ACTIVE COMPARATOR

Patients receive a partially resorbable bone substitute (Apatos®) to fill the gap between the implant and the buccal bone wall during immediate post-extraction implant placement.

Biological: Apatos® (partially resorbable bone substitute)

Interventions

Collagenated heterologous cortico-cancellous porcine bone mix + thermogelling copolymer with collagen (GTO®, OsteoBiol®, Tecnoss®)

Resorbable Bone Substitute (GTO®)

Porcine cortical bone granules (Apatos Cortical®, OsteoBiol®, Tecnoss®) stabilized with TSV Gel®, a thermogelling copolymer with collagen.

Partially Resorbable Bone Substitute (Apatos®)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient requiring at least one single immediate post-extractive implant.
  • At least 18 year old, able to understand and to sign an informed consent
  • There must be sufficient bone to allow the placement of at least a 3.5 mm diameter and 8.5 mm long implant.
  • After tooth extraction there must be a potential gap of at least 2 mm from the buccal inner bone plate and the implant surface.

You may not qualify if:

  • General contraindications to implant surgery.
  • Immunosuppressed or immunocompromised patients.
  • Patients irradiated in the head and/or neck.
  • Uncontrolled diabetes.
  • Pregnancy or lactation.
  • Active periodontal disease
  • Poor oral hygiene and motivation.
  • Addiction to alcohol or drugs.
  • Psychiatric problems and/or unrealistic expectations
  • Patients with an acute infection (abscess) in the site intended for implant placement.
  • Patients unable to commit to a 5-year follow-up.
  • Patients treated or under treatment with intravenous amino-bisphosphonates.
  • patients referred only for implant placement if follow-ups cannot be done at treatment centre.
  • Patients participating in other studies, if the present protocol could not be fully adhered to. In case of doubts please contact the study coordinator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King Juan Carlos University

Madrid, Madrid, 28933, Spain

Location

Related Publications (4)

  • Furhauser R, Florescu D, Benesch T, Haas R, Mailath G, Watzek G. Evaluation of soft tissue around single-tooth implant crowns: the pink esthetic score. Clin Oral Implants Res. 2005 Dec;16(6):639-44. doi: 10.1111/j.1600-0501.2005.01193.x.

    PMID: 16307569BACKGROUND
  • Thalmair T, Fickl S, Schneider D, Hinze M, Wachtel H. Dimensional alterations of extraction sites after different alveolar ridge preservation techniques - a volumetric study. J Clin Periodontol. 2013 Jul;40(7):721-7. doi: 10.1111/jcpe.12111. Epub 2013 May 5.

    PMID: 23647007BACKGROUND
  • De Angelis N, Felice P, Pellegrino G, Camurati A, Gambino P, Esposito M. Guided bone regeneration with and without a bone substitute at single post-extractive implants: 1-year post-loading results from a pragmatic multicentre randomised controlled trial. Eur J Oral Implantol. 2011 Winter;4(4):313-25.

    PMID: 22282729BACKGROUND
  • Esposito M, Grusovin MG, Polyzos IP, Felice P, Worthington HV. Interventions for replacing missing teeth: dental implants in fresh extraction sockets (immediate, immediate-delayed and delayed implants). Cochrane Database Syst Rev. 2010 Sep 8;2010(9):CD005968. doi: 10.1002/14651858.CD005968.pub3.

    PMID: 20824846BACKGROUND

MeSH Terms

Conditions

Alveolar Bone Loss

Condition Hierarchy (Ancestors)

Bone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Marco Esposito, Dentistry

    Associate Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 24, 2025

First Posted

July 2, 2025

Study Start

December 18, 2018

Primary Completion

December 20, 2025

Study Completion (Estimated)

December 20, 2030

Last Updated

July 4, 2025

Record last verified: 2025-07

Locations